April 13, 2021 2:10 PM
DBT approves additional funding for clinical studies of mRNA-based COVID-19 vaccine HGCO19
<span style="color: #222222;">The Department of Biotechnology (DBT) has announced that it has approved additional funding for clinical studies of mRNA-based COVID-19 vaccine - HGCO19. This funding has been provided under the Mission COVID Suraksha. </span><br />'' <br />'' <span style="color: #222222;">The vaccine is developed by Pune based biotechnology company Gennova Biopharmaceuticals Limited. The company has initiated the process to...